Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Cardiomyocyte-targeted and 17β-estradiol-loaded acoustic nanoprobes as a theranostic platform for cardiac hypertrophy

Fig. 3

Echogenic properties of PCM-E2/PFPs in vitro and in vivo. a, b In vitro US images of PCM-E2/PFPs (1 mg/mL) in degassed water detected at various frequencies of LIFU (1.2, 1.6, 2.4 and 3.2 W/cm2). c, d In vitro US images of PCM-E2/PFPs at different imaging time points. e, f In vivo US imaging ability of PCM-E2/PFPs + LIFU compared to E2/PFPs + LIFU, PCM-E2/PFPs and Sonovue in the same experiment condition. *p < 0.05 vs PCM-E2/PFPs + LIFU group

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us